347 related articles for article (PubMed ID: 32117687)
1. Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to
Becker A; Kreitmann L; Triffaut-Fillit C; Valour F; Mabrut E; Forestier E; Lesens O; Cazorla C; Descamps S; Boyer B; Chidiac C; Lustig S; Montbarbon E; Batailler C; Ferry T
J Bone Jt Infect; 2020; 5(1):28-34. PubMed ID: 32117687
[No Abstract] [Full Text] [Related]
2. Should we expand the indications for the DAIR (debridement, antibiotic therapy, and implant retention) procedure for Staphylococcus aureus prosthetic joint infections? A multicenter retrospective study.
Lesens O; Ferry T; Forestier E; Botelho-Nevers E; Pavese P; Piet E; Pereira B; Montbarbon E; Boyer B; Lustig S; Descamps S;
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1949-1956. PubMed ID: 30083889
[TBL] [Abstract][Full Text] [Related]
3. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention.
Lora-Tamayo J; Murillo O; Iribarren JA; Soriano A; Sánchez-Somolinos M; Baraia-Etxaburu JM; Rico A; Palomino J; Rodríguez-Pardo D; Horcajada JP; Benito N; Bahamonde A; Granados A; del Toro MD; Cobo J; Riera M; Ramos A; Jover-Sáenz A; Ariza J;
Clin Infect Dis; 2013 Jan; 56(2):182-94. PubMed ID: 22942204
[TBL] [Abstract][Full Text] [Related]
4. Truth in DAIR: Duration of Therapy and the Use of Quinolone/Rifampin-Based Regimens After Debridement and Implant Retention for Periprosthetic Joint Infections.
Tai DBG; Berbari EF; Suh GA; Lahr BD; Abdel MP; Tande AJ
Open Forum Infect Dis; 2022 Sep; 9(9):ofac363. PubMed ID: 36072695
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Optimal Duration of Adjunctive Rifampin Treatment in the Management of
Suzuki H; Goto M; Nair R; Livorsi DJ; Sekar P; Ohl ME; Diekema DJ; Perencevich EN; Alexander B; Jones MP; McDaniel JS; Schweizer ML
Open Forum Infect Dis; 2022 Sep; 9(9):ofac473. PubMed ID: 36196299
[TBL] [Abstract][Full Text] [Related]
6. Implant Removal in the Management of Prosthetic Joint Infection by
Gómez-Junyent J; Lora-Tamayo J; Baraia-Etxaburu J; Sánchez-Somolinos M; Iribarren JA; Rodriguez-Pardo D; Praena-Segovia J; Sorlí L; Bahamonde A; Riera M; Rico A; Del Toro MD; Morata L; Cobo J; Falgueras L; Benito N; Muñez E; Jover-Sáenz A; Pigrau C; Ariza J; Murillo O
Antibiotics (Basel); 2021 Jan; 10(2):. PubMed ID: 33530523
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of Acute Periprosthetic Infections with DAIR (Debridement, Antibiotics and Implant Retention) - Success Rate and Risk Factors of Failure].
Abrman K; Musil D; Stehlík J
Acta Chir Orthop Traumatol Cech; 2019; 86(3):181-187. PubMed ID: 31333181
[TBL] [Abstract][Full Text] [Related]
8. Debridement, antibiotics and implant retention (DAIR): An effective treatment option for early prosthetic joint infections.
Tatarelli P; Romani T; Santoro V; Spezia M; Gallo A; Ripamonti G; Carducci M; Trotti C; Parisini A; Nicolini LA; Mikulska M; Borrè S; Bassetti M
J Infect Chemother; 2021 Aug; 27(8):1162-1168. PubMed ID: 33781690
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of Outcomes of Culture positive and Culture negative Acute Knee Prosthetic Joint Infection following Debridement, Antibiotics and Implant Retention (DAIR).
Soundarrajan D; Rajkumar N; Dhanasekararaja P; Rithika S; Rajasekaran S
Eur J Orthop Surg Traumatol; 2023 Aug; 33(6):2375-2383. PubMed ID: 36436089
[TBL] [Abstract][Full Text] [Related]
10. The Role of Long-Term Antibiotic Suppression in the Management of Peri-Prosthetic Joint Infections Treated With Debridement, Antibiotics, and Implant Retention: A Systematic Review.
Malahias MA; Gu A; Harris EC; Adriani M; Miller AO; Westrich GH; Sculco PK
J Arthroplasty; 2020 Apr; 35(4):1154-1160. PubMed ID: 31955984
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic therapy duration for prosthetic joint infections treated by Debridement and Implant Retention (DAIR): Similar long-term remission for 6 weeks as compared to 12 weeks.
Chaussade H; Uçkay I; Vuagnat A; Druon J; Gras G; Rosset P; Lipsky BA; Bernard L
Int J Infect Dis; 2017 Oct; 63():37-42. PubMed ID: 28804007
[TBL] [Abstract][Full Text] [Related]
12. Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study-The ARTHR-IS Study Group.
Espíndola R; Vella V; Benito N; Mur I; Tedeschi S; Zamparini E; Hendriks JGE; Sorlí L; Murillo O; Soldevila L; Scarborough M; Scarborough C; Kluytmans J; Ferrari MC; Pletz MW; Mcnamara I; Escudero-Sanchez R; Arvieux C; Batailler C; Dauchy FA; Liu WY; Lora-Tamayo J; Praena J; Ustianowski A; Cinconze E; Pellegrini M; Bagnoli F; Rodríguez-Baño J; Del Toro MD;
Infect Dis Ther; 2022 Dec; 11(6):2177-2203. PubMed ID: 36242742
[TBL] [Abstract][Full Text] [Related]
13. Does a New Antibiotic Scheme Improve the Outcome of
Auñón Á; Tovar-Bazaga M; Blanco-García A; García-Cañete J; Parrón R; Esteban J
Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884176
[TBL] [Abstract][Full Text] [Related]
14. Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy.
Cobo J; Miguel LG; Euba G; Rodríguez D; García-Lechuz JM; Riera M; Falgueras L; Palomino J; Benito N; del Toro MD; Pigrau C; Ariza J
Clin Microbiol Infect; 2011 Nov; 17(11):1632-7. PubMed ID: 20678178
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Debridement, Antibiotics and Implant Retention (DAIR) for Periprosthetic Joint Infection in a High-Volume Arthroplasty Centre.
Walkay S; Wallace DT; Balasubramaniam VSC; Maheshwari R; Changulani M; Sarungi M
Indian J Orthop; 2022 Aug; 56(8):1449-1456. PubMed ID: 35928667
[TBL] [Abstract][Full Text] [Related]
16. Early Staphylococcal Periprosthetic Joint Infection (PJI) Treated with Debridement, Antibiotics, and Implant Retention (DAIR): Inferior Outcomes in Patients with Staphylococci Resistant to Rifampicin.
Eriksson HK; Lazarinis S; Järhult JD; Hailer NP
Antibiotics (Basel); 2023 Nov; 12(11):. PubMed ID: 37998791
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of joint failure in hip prostheses infected with Staphylococcus aureus treated with debridement, antibiotics and implant retention compared to Streptococcus.
Betz M; Abrassart S; Vaudaux P; Gjika E; Schindler M; Billières J; Zenelaj B; Suvà D; Peter R; Uçkay I
Int Orthop; 2015 Mar; 39(3):397-401. PubMed ID: 25183296
[TBL] [Abstract][Full Text] [Related]
18. Success Rates of Debridement, Antibiotics, and Implant Retention in 230 Infected Total Knee Arthroplasties: Implications for Classification of Periprosthetic Joint Infection.
Zhu MF; Kim K; Cavadino A; Coleman B; Munro JT; Young SW
J Arthroplasty; 2021 Jan; 36(1):305-310.e1. PubMed ID: 32868114
[TBL] [Abstract][Full Text] [Related]
19. Outcomes and risk factors for failure after débridement, antibiotics, and implant retention for elbow periprosthetic joint infection.
Tai DBG; Hanson S; Brennan P; Suh GA; Esper RN; Sanchez-Sotelo J
J Shoulder Elbow Surg; 2023 Mar; 32(3):475-479. PubMed ID: 36565739
[TBL] [Abstract][Full Text] [Related]
20. Does Prior Failed Debridement Compromise the Outcome of Subsequent Two-Stage Revision Done for Periprosthetic Joint Infection Following Total Knee Arthroplasty?
Rajgopal A; Panda I; Rao A; Dahiya V; Gupta H
J Arthroplasty; 2018 Aug; 33(8):2588-2594. PubMed ID: 29627258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
